Nvidia’s earnings and Anthropic’s market debut offer two ways to bet on AI as Wall Street struggles through a fourth-quarter selloff.
4 minute read
Consumers are looking to tighten their belts, but the world’s largest electronics company is benefiting nevertheless.
The firm has multiple catalysts that could generate a rally of 35% for the stock.
Long Read
Klarna stock rises after reporting strong customer growth and an increase in transaction margin dollars in the third quarter.
3 minute read
Viking Holdings misses quarterly earnings and revenue estimates. Investors will need to look past the quarter.
2 minute read
November 16, 2026
Nvidia’s stock hasn’t worked for a while now, and that was with Jensen Huang as CEO. His surprise resignation is a chance for investors to reassess.
Long Read
The biotech plans to reinvest in its pipeline, particularly oncology treatments like its personalized cancer vaccine.
3 minute read
Blackstone Life Sciences agrees to pay $1.5 billion in development costs for Pfizer’s berobenatide through 2028 in exchange for milestone-based payments.
2 minute read
Optimists cite robust earnings growth; the pessimists see a bubble in danger of bursting. Plus, pro forecasts for rates, international markets, the midterm, and more.
Long Read
In our latest Big Money poll, professional investors are more upbeat than six months ago and see plenty of opportunities for stocks. Where they’re putting money to work.
Long Read
Carriers’ shares got a boost on Monday, as the worst of the weekend’s travel chaos looks to be over.
1 minute read
Buying out Double Eagle’s 40% stake lets Diamondback capture more revenue from wells it was already planning to drill.
3 minute read
The latest addition to Concurrent’s platform continues a year of rapid growth with assets under management now topping $30 billion.
2 minute read
Demand for tax-aware long/short strategies has soared and tested Schwab’s ability to make them available for advisors.
3 minute read
Barron's ranks the best advisors, firms, and teams in the country. The goal is to shine a spotlight on the nation's best financial advisors, with an eye toward raising standards in the industry.
Are you ready to search for a financial advisor? We'll match you with advisors who can help.
Includes common stocks, ADRs and REITs listed on NYSE, Nasdaq or NYSE American with a prior day close of $2 a share or higher and volume of at least 50,000
| Company (Ticker) | Change Percent | Price |
|---|---|---|
| SELLAS Life Sciences Group Inc. (SLS) | 159.44% | $19.38 |
| Tucows Inc. (TCX) | 34.02% | $15.34 |
| Greenwich LifeSciences Inc. (GLSI) | 30.67% | $17.98 |
| Cingulate Inc. (CING) | 24.27% | $4.66 |
| New Fortress Energy Inc. Cl A (NFE) | 23.61% | $3.77 |